Title Image

Labial herpes

Launched or under launch (2013-2015): Australia, Austria, Canada, Chile, Colombia, Denmark,Egypt, Israel, Jordan, Malaysia, Middle East, Montenegro, New Zealand, Romania, Serbia, South Africa, Spain, Tunisia.

HERPECILIN – Labial Herpes

6mL (tube) Class IIa Medical Device for the treatment of open Labial Herpes lesions (Official Indication)

LABIAL HERPES (Cold sore, Herpes Simplex Labialis)

Physiopathology: After initial infection, HSV1 ascends nerve axons & remains latent in the ganglia, until it gets activated by a trigger & migrates to the skin and mucosa surface. A vesicle develops where the virus multiplies. The open lesion then sheds large amounts of free virus particles which infect new host cells, spreading the infection & lesions, resulting in cellular destruction, inflammation, pain & burning sensation.

Ideal Treatment Approach: An ideal treatment should stop virus activation, but such a treatment should be administered as soon as the virus is activated. Oral Acyclovir may be a good antiviral but should be administered before the virus reaches oral mucosa (preventive treatment).

Currently Available Treatments:  

  • Topical Anti-Viral: none
  • Intracellular Virus inhibitors: Acyclovirs such as Zovirax, etc… → Good as preventive but not effective at all on free virus.
  • Symptomatic: topical anesthetics, antiseptics, analgesics, protective or hydrating films.

None of these treatments is capable of neutralizing the virus & stopping further infection, blocking inflammation & pain, or stimulating instant lesion healing so as to minimize pain & irritation.

 

VITROBIO‘s Completely NEW Therapeutic Approach:

VITROBIO elaborated a patented glycerol-based filmogen viscous solution, glycerol being commonly used as pharmaceutical excipient & 18 times more osmotically active than Sea Water yet NON-IRRITANT (International patents: PCT/FR99/01340 &  PCT/EP2013/061835). The hypertonic solution film attracts hypotonic fluids from the lesion surface and dislodges all contaminants, including virus particles and bacteria, reduces pain & irritation and promotes a clean, favorable environment conducive to accelerated lesion healing. Due to instant the mechanical effects consisting in cleaning & protecting the sore, it helps neutralize the infection, heal the lesion & provides symptomatic relief (including local inflammation and pain) very fast. Herpecilin is the 1st, topical, safe, new generation of topical cold sore treatment.

Product Presentation: 6mL tube

Posology: Apply a few drops on the lesion, 3 to 4 times a day until complete recovery.

Regulatory Status: Due to the mechanical topical filmogen activity without any pharmacological, biological, metabolic or immunological interaction with the cellular structure:  Class IIa Medical Device in Europe.

Contraindications: None

Side Effects: None

Clinical Efficacy: Full trial published in Int J Biological & Pharmaceutical Res. 2013; 4(4): 242-249; e-ISSN: 0976-3651.

Conclusion: 1st topical Cleaning & Healing Gel for Cold Sores